Baker McKenzie advises Hodogaya Chemical on its Acquisition of Hungarian Chemical Manufacturer Framochem

Baker & McKenzie (Gaikokuho Joint Enterprise) (“Baker McKenzie”) advised Hodogaya Chemical Co., Ltd. (“Hodogaya Chemical”; TSE: 4112), a chemical manufacturer founded in 1916, in connection with its acquisition of 100% of the equity interests in Framochem Francia-Magyar Finomkemiai Kft (“Framochem”), a Hungarian chemical manufacturer. The completion of this acquisition is subject to satisfaction of the conditions set forth in a Quota Purchase Agreement with the equity holders of Framochem.

Framochem manufactures and sells Active Pharmaceutical Ingredients (APIs), intermediates and fine chemical products, primarily using phosgene as a key raw material. Phosgene is a reactant widely used in the manufacturing processes of a broad range of products, including resins, pharmaceuticals and agricultural chemicals, and demands rigorous safety management and advanced professional expertise. Through this transaction, Hodogaya Chemical will acquire a manufacturing base in Europe.

The Baker McKenzie team was led by Akifusa Takada, Managing Partner of the Tokyo office and Partner in the Corporate / M&A Group, and supported by Associates Kazuaki Tsukahara and Masayuki Shinoura. Baker McKenzie Budapest office Partner Akos Fehervary and Associates Ferenc David and Andras Felix Kovac advised and supported Hodogaya Chemical on this transaction.